Welcome to a new era for clinical labs. The NovaSeq ™ 6000Dx is Illumina's first IVD high-throughput sequencing instrument for the clinical lab. Push the boundaries of clinical genomics with ...

Illumina is an applied genomics technology company that was founded in 1998 with the mission statement: ‘To improve human health by unlocking the power of the genome’. Over the past two ...

But Illumina’s divestment of Grail isn’t the ... Exact Sciences reported on a 6,000-sample study of a multi-cancer test it plans to offer alongside single-cancer screening products such ...

Shares of Illumina (NASDAQ: ILMN) were falling on Friday. The company's stock was down by as much as 11.4% early in the session, and was still off by 8.7% as of 2:38 p.m. ET. At that time ...